Medicine Description certican 0.25mg
Certican 0.25 mg 60 tablets is a medication that contains everolimus, a potent immunosuppressant that functions by inhibiting the mammalian target of rapamycin (mTOR). This inhibition leads to a reduction in the activation and proliferation of T-lymphocytes and B-lymphocytes, which are key components of the immune response responsible for recognizing and attacking foreign tissues, such as transplanted organs. By modulating the immune system, everolimus decreases the likelihood of acute and chronic rejection episodes after solid organ transplants. Furthermore, everolimus also impacts several signaling pathways essential for cell survival and growth, contributing to its role in maintaining organ function and improving patient outcomes post-transplant. It is typically used in conjunction with other immunosuppressants to achieve a synergistic effect that enhances the overall efficacy of the immunosuppressive regimen.
Indications and Uses of Certican 0.25 mg 60 tablets
- Prevention of organ rejection in patients who have undergone kidney transplantation.
- Prevention of organ rejection in patients who have received a liver transplant.
- Prevention of organ rejection in patients who have undergone heart transplantation.
Side Effects of Certican 0.25 mg 60 tablets
- Increased risk of infections due to immunosuppression.
- Possible kidney dysfunction or changes in renal function.
- Elevated cholesterol and triglyceride levels.
- Gastrointestinal disturbances such as nausea and diarrhea.
- Skin reactions, including rash or acne.
- Potential lung complications, including pneumonitis.
Storage and Handling
Store Certican at room temperature, away from moisture and heat. Ensure that the medication is kept in its original packaging and out of reach of children. Do not use the product after the expiration date printed on the label.
Patient Advice and Precautions
Patients should follow their healthcare provider's instructions closely regarding monitoring and follow-up visits. Regular blood tests are essential to assess drug levels and organ function. It is crucial to report any signs of infection, unusual bleeding, or symptoms of organ rejection promptly. Avoid live vaccines while on this treatment and discuss any other medications or supplements with your healthcare provider to prevent potential interactions.